Comments
J&J to pay $158 million to settle Texas Risperdal case
20.01.2012. | AUSTIN, Texas (Reuters) - Johnson & Johnson said on Thursday it will pay $158 million to settle a Texas lawsuit accusing the drugmaker of improperly marketing its Risperdal anti-psychotic drug to state residents on the Medicaid health program for the poor....
